Sign In

Nick Wang

Oncology Lead, Great China & Intercontinental Region at GSK

Nick Wang is the Oncology Lead for Greater China & Intercontinental Region at GSK (GlaxoSmithKline).13 He has extensive experience in the pharmaceutical industry, particularly in sales, marketing, and business development and licensing (BD&L).1 Wang is based in London, United Kingdom.3

Wang has been actively involved in GSK's oncology initiatives. In July 2022, he shared news about GSK's acquisition of Sierra Oncology, demonstrating his engagement with the company's strategic developments.2 Additionally, in August 2020, Wang celebrated GSK's milestone of receiving EU approval for Blenrep, an oncology treatment.4

His role at GSK involves leadership and management responsibilities in the oncology division, focusing on the Greater China and Intercontinental regions.13 This position likely requires him to oversee GSK's oncology business strategies and operations in these key markets.

Highlights

Dec 20 · gsk.com
[PDF] GSK enters exclusive license agreement with Hansoh for HS-20093
Apr 19 · medinfo.gsk.com
[PDF] Utility of Circulating Tumor DNA in Lung Cancer Clinical Research ...

Related Questions

What are Nick Wang's main responsibilities at GSK?
How long has Nick Wang been with GSK?
What is Nick Wang's educational background?
What other roles has Nick Wang held in the pharmaceutical industry?
How has Nick Wang contributed to GSK's oncology portfolio?
Nick Wang
Add to my network

Location

Singapore